Searched for
ANTIMICROBIAL DRUGS
Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...
Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
If you have the patience, you can achieve innovation milestones, says Wockhardt chairman Habil KhorakiwalaWockhardt Hospitals is set to launch its antibiotic Zaynich in the US. Zahabiya Khorakiwala will lead US operations. The drug is expected t...
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
All central science and innovation schemes to be rolled out in West BengalMajor central science and innovation schemes are now active in West Bengal. Union Minister Jitendra Singh met with West Bengal Chief Minist...
Drugmakers flag concerns over blue-strip antibiotic labelsThe government mandated a blue line on antibiotic packaging to curb misuse. However, pharmaceutical companies argue this will disrupt opera...
Regulator set to monitor antimicrobial resistanceTo combat antimicrobial resistance (AMR), India's drug regulatory authority is collaborating with the Department of Animal Husbandry and Da...
Govt asks doctors, pharmacists to mention reasons for prescribing antibioticsThe Union Health Ministry has called for doctors to mention the indication and reason for prescribing antibiotics. This is in response to t...
Sustained rise in antimicrobial resistance in India: ICMR studyThis is the fifth detailed report on antimicrobial resistance (AMR) trends and patterns from the country published by the ICMR. This year's...
Antibiotics in development not enough to tackle 'superbugs'- WHOOut of the 43 antibiotics in development, the WHO said 26 drugs target the 13 most dangerous "superbugs". But the health agency said most o...
Pharma companies Cipla & Wockhardt in global alliance to fight drug resistanceThe other companies in the alliance include global majors such as Johnson & Johnson, Novartis, Pfizer, Sanofi and AstraZeneca.
New drug effective against antibiotic-resistant 'superbugs'On the tail end of HIV surface protein, there is a sequence of amino acids that the virus uses to "punch into" and infect cells.
Scottish, Indian varsities partner for research, innovationUniversity of Dundee has signed an MoU with Bangalore Bio Cluster to create a joint Drug Discovery Centre to tackle antimicrobial resistanc...
Antibiotic crisis needs united global response: ExpertsGrowing resistance to antibiotics and other drugs demands a co-ordinated global response on the same scale as efforts to address climate ch...
- Superbug threat: Govt mulls introducing new 'schedule' in Act
The threat of a multi-drug resistant superbug looming large has forced the government to consider introduction of a separate schedule in th...